PNEUMONIA : Impact Factor & More
eISSN: 2200-6133pISSN: 2200-6133
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on PNEUMONIA
PNEUMONIA Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2090 | USD 2490 | GBP 1790 |
| Publication Time | 11 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in PNEUMONIA ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in PNEUMONIA
The heterogeneous treatment effect of adjuvant therapy with corticosteroids in patients with Community-Acquired Pneumonia: a review.
- 25 Apr 2026
- Pneumonia (Nathan Qld.)
Health disparities in the burden of pneumococcal disease in US adults.
- 7 Apr 2026
- Pneumonia (Nathan Qld.)
Prognosis of clinical pneumonia in undernourished children in rural Gambia.
- 25 Mar 2026
- Pneumonia (Nathan Qld.)
Eosinopenia and prognosis in severe community-acquired pneumonia.
- 25 Mar 2026
- Pneumonia (Nathan Qld.)
Biomarker-guided use of corticosteroids in pneumonia.
- 25 Feb 2026
- Pneumonia (Nathan Qld.)
Corticosteroids in severe community-acquired pneumonia: friend, foe or both?
- 5 Feb 2026
- Pneumonia (Nathan Qld.)
The heterogeneous treatment effect of adjuvant therapy with corticosteroids in patients with Community-Acquired Pneumonia: a review.
- 25 Apr 2026
- Pneumonia (Nathan Qld.)
Health disparities in the burden of pneumococcal disease in US adults.
- 7 Apr 2026
- Pneumonia (Nathan Qld.)
Prognosis of clinical pneumonia in undernourished children in rural Gambia.
- 25 Mar 2026
- Pneumonia (Nathan Qld.)
Eosinopenia and prognosis in severe community-acquired pneumonia.
- 25 Mar 2026
- Pneumonia (Nathan Qld.)
Biomarker-guided use of corticosteroids in pneumonia.
- 25 Feb 2026
- Pneumonia (Nathan Qld.)
Corticosteroids in severe community-acquired pneumonia: friend, foe or both?
- 5 Feb 2026
- Pneumonia (Nathan Qld.)
FAQs on PNEUMONIA
How long has PNEUMONIA been actively publishing? 
What is the publishing frequency of PNEUMONIA?
How many articles did PNEUMONIA publish last year?
What is the eISSN & pISSN for PNEUMONIA?
Who is the publisher of PNEUMONIA?
